NORTHERN TRUST CORP - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 92 filers reported holding UTAH MED PRODS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$3,196,276
-7.8%
37,166
-0.0%
0.00%0.0%
Q2 2023$3,464,897
-3.4%
37,177
-1.8%
0.00%0.0%
Q1 2023$3,586,665
-5.3%
37,846
+0.4%
0.00%0.0%
Q4 2022$3,789,378
+19.8%
37,694
+1.6%
0.00%0.0%
Q3 2022$3,164,000
-1.1%
37,093
-0.4%
0.00%0.0%
Q2 2022$3,198,000
-3.9%
37,234
+0.5%
0.00%0.0%
Q1 2022$3,328,000
-13.3%
37,040
-3.5%
0.00%0.0%
Q4 2021$3,840,000
+6.3%
38,400
-1.4%
0.00%0.0%
Q3 2021$3,614,000
+4.8%
38,926
-4.0%
0.00%0.0%
Q2 2021$3,447,000
-7.7%
40,535
-6.1%
0.00%0.0%
Q1 2021$3,736,000
-13.8%
43,146
-16.0%
0.00%0.0%
Q4 2020$4,333,000
-1.5%
51,391
-6.7%
0.00%0.0%
Q3 2020$4,399,000
-13.0%
55,087
-3.5%
0.00%0.0%
Q2 2020$5,058,000
-6.3%
57,083
-0.5%
0.00%
-50.0%
Q1 2020$5,397,000
-11.0%
57,383
+2.1%
0.00%
+100.0%
Q4 2019$6,063,000
+10.8%
56,191
-1.5%
0.00%0.0%
Q3 2019$5,470,000
+5.1%
57,066
+4.9%
0.00%0.0%
Q2 2019$5,205,000
+7.0%
54,380
-1.3%
0.00%0.0%
Q1 2019$4,863,000
+6.7%
55,099
+0.5%
0.00%0.0%
Q4 2018$4,557,000
-14.6%
54,848
-3.2%
0.00%0.0%
Q3 2018$5,337,000
-12.6%
56,655
+2.3%
0.00%
-50.0%
Q2 2018$6,103,000
+16.0%
55,406
+4.1%
0.00%
+100.0%
Q1 2018$5,263,000
+22.3%
53,248
+0.7%
0.00%0.0%
Q4 2017$4,302,000
+11.0%
52,860
+0.3%
0.00%0.0%
Q3 2017$3,877,000
+0.5%
52,712
-1.1%
0.00%0.0%
Q2 2017$3,858,000
+16.9%
53,294
+0.6%
0.00%0.0%
Q1 2017$3,301,000
-12.9%
52,989
+1.8%
0.00%0.0%
Q4 2016$3,789,000
+23.5%
52,073
+1.5%
0.00%0.0%
Q3 2016$3,068,000
-3.0%
51,312
+2.2%
0.00%0.0%
Q2 2016$3,164,000
-4.0%
50,209
-4.7%
0.00%0.0%
Q1 2016$3,296,000
+8.7%
52,698
+1.7%
0.00%0.0%
Q4 2015$3,031,000
+8.5%
51,793
-0.1%
0.00%0.0%
Q3 2015$2,793,000
-8.8%
51,841
+1.0%
0.00%0.0%
Q2 2015$3,061,000
-2.9%
51,326
-2.6%
0.00%0.0%
Q1 2015$3,153,000
-3.9%
52,679
-3.5%
0.00%0.0%
Q4 2014$3,280,000
+23.6%
54,613
+0.3%
0.00%0.0%
Q3 2014$2,654,000
+2.5%
54,424
+8.1%
0.00%0.0%
Q2 2014$2,590,000
-19.8%
50,356
-9.9%
0.00%0.0%
Q1 2014$3,231,000
-3.2%
55,863
-4.3%
0.00%0.0%
Q4 2013$3,338,000
-2.9%
58,398
+1.0%
0.00%0.0%
Q3 2013$3,436,000
+4.3%
57,808
-4.7%
0.00%0.0%
Q2 2013$3,294,00060,6630.00%
Other shareholders
UTAH MED PRODS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Clean Yield Group 49,094$3,535,0001.48%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 27,464$1,988,0000.72%
Ativo Capital Management LLC 16,525$1,196,0000.33%
Ancora Advisors LLC 55,159$3,993,0000.26%
ISTHMUS PARTNERS, LLC 10,754$779,0000.23%
Cardinal Capital Management 9,180$665,0000.22%
Acrospire Investment Management LLC 1,919$139,0000.13%
Penobscot Investment Management Company, Inc. 4,000$290,0000.09%
TFS CAPITAL LLC 3,226$234,0000.09%
WCM INVESTMENT MANAGEMENT, LLC 81,912$5,930,0000.09%
View complete list of UTAH MED PRODS INC shareholders